These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1782327

  • 1. Anti-ligand antibodies as potential autoantigens: in vitro and in vivo characteristics of anti-bungarotoxin antibodies in the idiotype network.
    Pachner AR, Itano AA, McCallum RM, Ricalton NS.
    Autoimmunity; 1991; 10(2):145-52. PubMed ID: 1782327
    [Abstract] [Full Text] [Related]

  • 2. Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes.
    Souroujon MC, Barchan D, Fuchs S.
    Immunol Lett; 1985; 9(6):331-6. PubMed ID: 3874156
    [Abstract] [Full Text] [Related]

  • 3. Mapping of a cholinergic binding site by means of synthetic peptides, monoclonal antibodies, and alpha-bungarotoxin.
    Conti-Tronconi BM, Tang F, Diethelm BM, Spencer SR, Reinhardt-Maelicke S, Maelicke A.
    Biochemistry; 1990 Jul 03; 29(26):6221-30. PubMed ID: 2207067
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal anti-acetylcholine receptor antibodies as probes for human acetylcholine-receptor in myasthenia gravis.
    Vincent A, Whiting PJ, Heidenreich F, Roberts A.
    J Recept Res; 1988 Jul 03; 8(1-4):143-59. PubMed ID: 3260283
    [Abstract] [Full Text] [Related]

  • 5. Isolation of an antiidiotypic antibody with acetylcholine-receptor-like binding properties from myasthenia gravis patients.
    Eng H, Lefvert AK.
    Ann Inst Pasteur Immunol; 1988 Jul 03; 139(5):569-80. PubMed ID: 3264701
    [Abstract] [Full Text] [Related]

  • 6. In vivo effects of neonatal administration of antiidiotype antibodies on experimental autoimmune myasthenia gravis.
    Verschuuren JJ, Graus YM, Van Breda Vriesman PJ, Tzartos S, De Baets MH.
    Autoimmunity; 1991 Jul 03; 10(3):173-9. PubMed ID: 1756222
    [Abstract] [Full Text] [Related]

  • 7. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
    Loutrari H, Kokla A, Trakas N, Tzartos SJ.
    Clin Exp Immunol; 1997 Sep 03; 109(3):538-46. PubMed ID: 9328134
    [Abstract] [Full Text] [Related]

  • 8. Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays.
    Pachner AR, Sourojon M, Fuchs S.
    J Neuroimmunol; 1986 Sep 03; 12(3):205-14. PubMed ID: 3488332
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal antibodies to the acetylcholine receptor by a normally functioning auto-anti-idiotypic mechanism.
    Cleveland WL, Wassermann NH, Sarangarajan R, Penn AS, Erlanger BF.
    Nature; 1986 Sep 03; 305(5929):56-7. PubMed ID: 6604226
    [Abstract] [Full Text] [Related]

  • 10. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
    Loutrari H, Tzartos SJ, Claudio T.
    Eur J Immunol; 1992 Nov 03; 22(11):2949-56. PubMed ID: 1385157
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding.
    Agius MA, Geannopoulos CJ, Fairclough RH, Richman DP.
    J Immunol; 1988 Jan 01; 140(1):62-8. PubMed ID: 3257231
    [Abstract] [Full Text] [Related]

  • 12. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
    Whiting PJ, Vincent A, Newsom-Davis J.
    J Neuroimmunol; 1983 Aug 01; 5(1):1-9. PubMed ID: 6874919
    [Abstract] [Full Text] [Related]

  • 13. beta-Bungarotoxin binding protein is immunogenic but lacks myasthenogenicity in rats.
    Qiao J, Wang ZY, Link H.
    J Neurol Sci; 1994 Feb 01; 121(2):190-3. PubMed ID: 8158214
    [Abstract] [Full Text] [Related]

  • 14. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW, Trinh VB, Gudipati E, Friend A, Page NA, Agius MA, Richman DP, Fairclough RH.
    Mol Immunol; 2014 Mar 01; 58(1):116-31. PubMed ID: 24333757
    [Abstract] [Full Text] [Related]

  • 15. Future therapeutic strategies in autoimmune myasthenia gravis.
    Psaridi-Linardaki L, Mamalaki A, Tzartos SJ.
    Ann N Y Acad Sci; 2003 Sep 01; 998():539-48. PubMed ID: 14592926
    [Abstract] [Full Text] [Related]

  • 16. Anti-acetylcholine receptor antibodies block bungarotoxin binding to native human acetylcholine receptor on the surface of TE671 cells.
    Pachner AR.
    Neurology; 1989 Aug 01; 39(8):1057-61. PubMed ID: 2761699
    [Abstract] [Full Text] [Related]

  • 17. Generation of acetylcholine receptor-specific human T cell lines using heterobifunctional antibody-targeted antigen presentation.
    Wang D, Nicolle MW.
    J Neuroimmunol; 1999 Sep 01; 99(1):114-21. PubMed ID: 10496184
    [Abstract] [Full Text] [Related]

  • 18. Idiotypic network connectivity and a possible cause of myasthenia gravis.
    Dwyer DS, Vakil M, Kearney JF.
    J Exp Med; 1986 Oct 01; 164(4):1310-8. PubMed ID: 2428915
    [Abstract] [Full Text] [Related]

  • 19. Receptor-like activity of a monoclonal anti-idiotypic antibody against an anti-acetylcholine receptor antibody.
    Lefvert AK, Fulpius BW.
    Scand J Immunol; 1984 May 01; 19(5):485-9. PubMed ID: 6729408
    [Abstract] [Full Text] [Related]

  • 20. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ, Sophianos D, Efthimiadis A.
    J Immunol; 1985 Apr 01; 134(4):2343-9. PubMed ID: 3973387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.